The protein encoded by ORF9 is essential for varicella-zoster virus (VZV) replication. Previous studies documented its presence in the trans-Golgi network and its involvement in secondary envelopment. In this work, we deleted the ORF9p acidic cluster, destroying its interaction with ORF47p, and this resulted in a nuclear accumulation of both proteins. This phenotype results in an accumulation of primary enveloped capsids in the perinuclear space, reflecting a capsid de-envelopment defect.
O
ne of the crucial steps in herpesviruses infection is capsid exit from the nucleus. This process mainly follows the envelopment/de-envelopment model, strongly documented by transmission electron microscopy (TEM) observations (1) . According to this model, nuclear capsids bud at the inner nuclear membrane (INM), thereby acquiring a primary envelope, which is then lost after fusion with the outer nuclear membrane (ONM), resulting in the release of naked capsids into the cytoplasm (1) .
Viral glycoproteins seem to play a role during this de-envelopment fusion process (2) . In the case of herpes simplex virus (HSV), it is known that gB and gH/gL, components of the viral entry machinery, are present at nuclear membranes and are likely responsible for this fusion (2, 3) . Moreover, the fusogenic role of gB seems to be mediated by its pUS3-dependent phosphorylation (4) . These hypotheses are supported by observations that HSV mutants lacking pUS3 or both gB and gH accumulate primary enveloped virions in the perinuclear space (3, 4) . The components of the nuclear export complex (NEC), pUL31 and pUL34, have been described to mediate the primary envelopment (2) . Phosphorylation of pUL31, another substrate of pUS3, also promotes the de-envelopment process (5) .
Unfortunately, the mechanisms leading to varicella-zoster virus (VZV) nuclear egress are still poorly understood, and it is not clear whether the role of these proteins is conserved in VZV egress. In this work, we destroyed the interaction of the essential VZV tegument protein ORF9p (6) with the viral kinase ORF47p, homologous to HSV-1 VP22 and UL13, respectively, and this affected their localization and impaired VZV de-envelopment.
ORF9 is the most transcribed VZV gene during infection (7), and ORF9p has been observed to be present in the trans-Golgi network (TGN) (8) , playing a role in secondary envelopment (9) . Within its sequence is an acidic motif corresponding to residues 85 to 93: EDDFEDIDE (Fig. 1B) . Acidic clusters are described as targeting signals to the TGN (10) , and the HSV VP22 acidic cluster has been shown to have a role in both correct protein subcellular localization and virion incorporation (11) . We thus deleted this acidic region to generate BAC-VZV-ORF9-⌬AC-V5 C-ter ( Fig.  1A and B) . Transfection of this bacterial artificial chromosome (BAC) into MeWo cells led to VZV-ORF9-⌬AC-V5 virus. Infection analysis revealed a significant defect in infectivity for this mutant, compared to that of the previously described VZV-ORF9-V5 (Fig. 1C) (9) . Generation of the revertant VZV-ORF9-rev-V5, achieved by replacing the ORF9-⌬AC sequence with the wild-type one, rescued this defect (Fig. 1C) .
In order to determine if this acidic region influences ORF9p localization, immunofluorescence analysis was performed on MeWo cells infected with VZV-ORF9-V5 ( Fig. 2A to C), VZV-ORF9-⌬AC-V5 ( Fig. 2D to F) , or VZV-ORF9-rev-V5 ( Fig. 2G to I). This experiment revealed the nuclear accumulation of ORF9p-⌬AC-V5 (Fig. 2D ), compared to ORF9p-V5 or ORF9p-rev-V5, which appeared to be mainly cytoplasmic ( Fig. 2A and G). ORF9p has been previously observed in the nucleus of infected cells by TEM analysis after immunogold labeling (8) and is characterized by the presence of two in silico-predicted nuclear localization signals (NLS) with the PSortII software (12); the first one has been confirmed to be active (13) . Moreover, it contains an active nuclear export signal (NES) (13) . This suggests that ORF9p can shuttle between the nucleus and cytoplasm, where its acidic region is thought to mediate its targeting to the TGN. Deletion of the ORF9p acidic region does not affect its isoelectric point or its in silico-predicted localization (PSortII prediction [12] ), but it strongly modifies its subcellular localization.
This acidic cluster overlaps the consensus sequence SEDD (Fig.  1B) , which we have previously described as being responsible for ORF47p-dependent phosphorylation (9) . We thus decided to check the ORF9p-⌬AC Western blotting pattern in the context of infection. As shown in Fig. 2J to K (lanes 2 to 4) , ORF9p-⌬AC migrated more quickly than ORF9p or ORF9p-rev in the gel, likely due to a reduced level of phosphorylation. In addition, coimmunoprecipitation experiments confirmed that the ORF9p-ORF47p interaction observed for the wild type and the revertant was lost in cells infected with this ⌬AC mutant (Fig. 2J and K, lanes 8) .
Moreover, immunofluorescence analysis indicated a stronger nuclear accumulation of ORF47p in VZV-ORF9-⌬AC-V5-infected cells (Fig. 2E ) than in VZV-ORF9-V5-or VZV-ORF9-rev-V5-infected cells (Fig. 2B and H) . This observation suggests an involvement of ORF9p in exporting ORF47p from the nucleus to the cytoplasm or in its cytoplasmic retention. All experiments were performed as previously described (9) .
In order to better understand the phenotype of this ⌬AC mu- tant, VZV-ORF9-V5-, VZV-ORF9-⌬AC-V5-, and VZV-ORF9-rev-V5-infected MeWo cells were analyzed by TEM 48 h postinfection (Fig. 3) . Surprisingly, the VZV-ORF9-⌬AC-V5-infected cells showed primary enveloped capsids that had accumulated in the perinuclear space (Fig. 3A to D versus E). Such perinuclear accumulation was observed in 32% of infected cells (up to 11 capsids/perinuclear structure), while it was observed in only 6% (maximum, 4 capsids) and 13% (maximum, 6 capsids) of wildtype-or revertant-infected cells, respectively (Fig. 3F) . Altogether, these observations could explain the infection defect of VZV-ORF9-⌬AC-V5. ORF9p could be directly involved in capsid egress or have an indirect role, regulating ORF47p localization, which could itself regulate VZV de-envelopment. Another possibility is that neither ORF9p nor ORF47p are involved in capsid egress, but nuclear misaccumulation of one or both of these proteins could have an adverse effect on de-envelopment. Nuclear and cytoplasmic extracts (14) from VZV-ORF9-V5-, VZV-ORF9-⌬AC-V5-, or VZV-ORF9-rev-V5-infected MeWo cells were further analyzed by Western blotting 24 h postinfection, in order to determine if the de-envelopment defect could be due to an altered expression level, stability, or localization pattern of gB, gH, ORF66p, ORF24p, or ORF27p, which are homologous to the HSV proteins involved in de-envelopment. The glycoprotein gE, described as an additional fusion protein during VZV entry (15) , was also analyzed, while IE63 was chosen as an infection control. No apparent difference was observed for any of these proteins (Fig. 4) , suggesting instead an independent role for ORF9p, which may act as a negative regulator of the fusion process. Observations of a pseudorabies mutant virus deleted for both gB and gH showed no defect in nuclear egress (16) ; indeed, this suggests that glycoprotein-mediated fusion is probably not the only mechanism involved in the de-envelopment process.
In summary, we showed that ORF9p is somehow involved in the ORF47p nuclear/cytoplasmic balance, and its acidic cluster was identified as an important determinant for ORF9p subcellular localization, ORF47p interaction, and VZV infectivity. We also found evidence that VZV nucleocapsid egress is impaired when the ORF9p acidic cluster is deleted.
